ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 243 out of 3593

$805K Total Retail Price of All Prescriptions

Rank: 221 out of 3593

799 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 799 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 799 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,785 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 983 862 1 4
PRAVASTATIN SODIUM 888 784 2 13
LISINOPRIL 689 629 3 2
AMLODIPINE BESYLATE 588 523 4 3
OMEPRAZOLE 444 387 5 5
CARVEDILOL 424 380 6 23
SIMVASTATIN 369 342 7 1
TRAMADOL HCL 330 276 8 17
METFORMIN HCL 291 254 9 6
LOSARTAN POTASSIUM 290 256 10 14
HYDROCODONE-ACETAMINOPHEN 283 211 S3 11 7
ATORVASTATIN CALCIUM 277 246 12 15
ZOLPIDEM TARTRATE 251 206 13 12
ATENOLOL 224 214 14 11
RANITIDINE HCL 223 175 15 27
GLIMEPIRIDE 208 184 16 44
GEMFIBROZIL 196 151 17 88
ALENDRONATE SODIUM 187 167 18 22
METOPROLOL TARTRATE 175 128 19 8
FUROSEMIDE 166 132 20 9
METOPROLOL SUCCINATE 162 161 21 19
CRESTOR 143 96 22 21
PAROXETINE HCL 142 127 23 62
SERTRALINE HCL 140 124 24 28
LOVASTATIN 130 130 25 20
ALLOPURINOL 125 108 26 35
GABAPENTIN 125 98 26 16
FLUTICASONE PROPIONATE 122 91 28 32
AZITHROMYCIN 122 93 28 34
HYDROCHLOROTHIAZIDE 117 114 30 10
TAMSULOSIN HCL 115 94 31 33
ZETIA 110 89 32 110
CITALOPRAM HBR 109 96 33 25
DONEPEZIL HCL 108 108 34 31
NIFEDIPINE ER 100 88 35 75
ADVAIR DISKUS 100 84 35 47
FENOFIBRATE 99 76 37 39
ENALAPRIL MALEATE 95 87 38 38
PREVALITE 95 90 10 38 527
NAMENDA 94 94 40 50
ISOSORBIDE MONONITRATE ER 91 71 41 61
TEMAZEPAM 88 76 42 56
METHYLPREDNISOLONE 88 72 42 103
WARFARIN SODIUM 87 74 44 18
LYRICA 83 56 45 105
CIPROFLOXACIN HCL 82 71 46 52
TRAZODONE HCL 82 40 46 53
FINASTERIDE 80 79 48 79
TERAZOSIN HCL 80 80 48 115
TRICOR 78 53 50 130
POTASSIUM CHLORIDE 77 65 51 24
MORPHINE SULFATE ER 73 33 S2 52 108
ALPRAZOLAM 72 63 53 37
OXYBUTYNIN CHLORIDE 72 60 53 104
IPRATROPIUM BROMIDE 72 67 53 210
DIGOXIN 66 65 56 58
BENAZEPRIL HCL 64 62 57 69
BUPROPION HCL SR 63 50 58 207
ANDROGEL 62 53 S3 59 320
LORATADINE 61 40 60 129
JANUVIA 59 34 61 81
NIFEDICAL XL 58 57 62 281
DOXAZOSIN MESYLATE 55 52 63 63
PRIMIDONE 54 54 64 282
CEPHALEXIN 54 46 64 150
PLAVIX 53 43 66 42
SPIRIVA 52 42 67 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.